Bipartisan Senate Bill Proposes Medicare Coverage for New Blood Tests That Detect Multiple Cancers Early
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Also known as: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Legislative Progress
Key Points
Impact Analysis
Milestones
Related News
4 articlesPBM Reforms, Restoration of Science Cuts Seen in $1.2T Spending Deal for 2026
The legislative package folded in a bill that calls on Medicare to fund multicancer early detection (MCED) testing starting in 2028. This law aligns our health care system with the pace of scientific innovation and brings us one step closer to a future where more cancers are found earlier.

Rep. Sewell's cancer screening bill advances unanimously in House committee
HR842, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act, passed the House Ways and Means Committee 43-0. The bill creates a pathway for Medicare to cover emerging diagnostic tools, once FDA-approved, which can screen for up to 40 cancers via blood test.
House Votes 341-88 for 'Minibus' Spending Package
The Consolidated Appropriations Act 2026 includes Medicare provisions that lay the groundwork for adding coverage for blood tests that can detect many different forms of cancer at the same time. The bill passed the House with broad bipartisan support and now heads to the Senate.